|
Market Closed -
Xetra
11:35:32 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 359.10 EUR | -2.41% |
|
+0.01% | +28.11% |
| 10-02 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 218B 194B 181B 165B 310B 20,983B 313B 2,188B 848B 10,700B 818B 800B 34,391B | P/E 2026 * |
25.5x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 259B 231B 215B 196B 370B 24,978B 373B 2,605B 1,010B 12,737B 974B 953B 40,938B | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 6.29x |
| Free-Float |
99.77% | Yield 2026 * |
2.5% | Yield 2027 * | 2.64% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Tradegate
| AMG | Real-time | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Börse Stuttgart
| AMG | Delayed | |
|
London S.E.
| 0R0T | Delayed | |
|
CBOE
| 0R0T | Real-time | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote |
Last Transcript: Amgen Inc.
| 1 day | -2.41% | ||
| 1 week | +0.01% | ||
| Current month | -3.77% | ||
| 1 month | -4.67% | ||
| 3 months | +10.49% | ||
| 6 months | +18.42% | ||
| Current year | +28.11% |
| 1 week | 357.5 |  | 376.75 |
| 1 month | 325.5 | | 381.65 |
| Current year | 271.8 | | 383.05 |
| 1 year | 247.65 | | 383.05 |
| 3 years | 230 | | 383.05 |
| 5 years | 174.58 | | 383.05 |
| 10 years | 120.65 | | 383.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.41% | +0.01% | - | - | 218B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.93% | -3.39% | +27.17% | +57.15% | 410.8B | |
| Weighted average by Cap. | -0.70% | -3.33% | +30.52% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 34.61B 32.26B 29.41B 55.47B 3,750B 56B 391B 152B 1,912B 146B 143B 6,146B | 40.31B 35.83B 33.4B 30.44B 57.43B 3,882B 57.97B 405B 157B 1,979B 151B 148B 6,362B |
| Net income | 8.58B 7.63B 7.11B 6.48B 12.22B 826B 12.34B 86.17B 33.4B 421B 32.21B 31.51B 1,354B | 9.39B 8.35B 7.78B 7.09B 13.38B 905B 13.51B 94.33B 36.56B 461B 35.26B 34.5B 1,482B |
| Net Debt | 41.49B 36.87B 34.37B 31.33B 59.1B 3,995B 59.67B 417B 161B 2,037B 156B 152B 6,548B | 35.82B 31.83B 29.67B 27.05B 51.03B 3,449B 51.51B 360B 139B 1,759B 134B 132B 5,653B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | €359.10 | -2.41% | 233 |
| 26-10-01 | €367.95 | -1.39% | 522 |
| 26-09-30 | €373.15 | +1.44% | 355 |
| 26-09-29 | €367.85 | +0.73% | 393 |
| 26-09-28 | €365.20 | +1.71% | 704 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
Select your edition
All financial news and data tailored to specific country editions
